Search Results

Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA.

• Authors : Lin, Shih-Wen; Shapouri, Sheila; Parisé, Hélène

Subjects: BUDGET; FOLLICULAR lymphoma; BUDGET cuts

• Source: PharmacoEconomics; May2024, Vol. 42 Issue 5, p569-582, 14p

Record details

Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States.

• Authors : Cho, Sang Kyu; Manzoor, Beenish S.; Sail, Kavita R.

• Source: PharmacoEconomics; Sep2020, Vol. 38 Issue 9, p941-951, 11p

Record details

Introduction of Glofitamab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after ≥2 Lines of Systemic Therapy Results in Cost Savings to the Healthcare System Based on a United States Budget Impact Analysis

• Authors : Mahmoudjafari, Zahra; Li, Jia; Bercaw, Eric

• Source: Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p7246-7246, 1p

Record details

Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.

• Authors : Saab, Sammy; Virabhak, Suchin; Parisé, Hélène

Subjects: THERAPEUTIC use of proteins; RIBAVIRIN; HYDROCARBONSUNITED States

• Source: Advances in Therapy; Aug2016, Vol. 33 Issue 8, p1316-1330, 15p

Record details

Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection

• Authors : Johnson, Scott J.; Parisé, Hélène; Virabhak, Suchin

• Source: Journal of Medical Economics; October 2016, Vol. 19 Issue: 10 p983-994, 12p

Record details

Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US

• Authors : Saab, Sammy; Parisé, Hélène; Virabhak, Suchin

• Source: Journal of Medical Economics; August 2016, Vol. 19 Issue: 8 p795-805, 11p

Record details

Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.

• Authors : Gradman AH; Parisé H; Lefebvre P

• Source: Hypertension (0194911X); Feb2013, Vol. 61 Issue 2, p309-318, 10p

Record details

Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.

• Authors : Manjunath, Ranjani; Emmanuel Paradis, Pierre; Parisé, Hélène

• Source: Neurology; 10/30/2012, Vol. 79 Issue 18, p1908-1916, 9p

Record details

JOSEPH A. PARISE

• Source: Philadelphia Inquirer, The (PA) and Philadelphia Daily News (PA), March 2, 2014 Death Notice - Classified, 2pp

Record details

Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers.

• Authors : Parisé, Hélène¹; Laliberté, François¹ ; Lefebvre, Patrick¹

Subjects: *MULTIPLE sclerosis; *DISEASE relapse; *CAREGIVERS

• Source: Journal of the Neurological Sciences. Jul2013, Vol. 330 Issue 1/2, p71-77. 7p.

Record details